In-use studies are critical for demonstrating how a drug product, reconstituted preparation, diluted solution, or opened container performs during the period when it is actively handled in real-world use. For pharmaceutical and biotech teams, these studies help answer practical questions that directly affect development decisions: whether the product remains physically stable after first puncture, whether assay and impurity profiles stay within expectation during infusion preparation, whether the formulation is compatible with contact materials, and whether the intended handling window is scientifically supportable. BOC Sciences provides tailored in-use studies for liquid, lyophilized, suspension, emulsion, and complex injectable products, integrating formulation understanding, analytical strategy, and protocol execution to generate data that supports confident CMC planning, partner discussions, and downstream product decisions.
We build study protocols around the actual product presentation, preparation steps, and administration pathway, often in alignment with broader formulation services strategies.
Our teams combine targeted analytical workflows with product knowledge to monitor visible change, potency trends, degradation behavior, and key quality indicators using an integrated analytical platform.
In-use performance often depends on the interface between the formulation and its environment. We therefore incorporate targeted compatibility analysis to examine the impact of diluents, syringes, tubing, filters, and storage containers.
We generate practical, decision-ready data packages that can be integrated with analytical development and quality control activities to support formulation refinement, tech transfer discussions, and lifecycle planning.
BOC Sciences helps teams understand how their products behave after opening, dilution, transfer, and short-term hold so development decisions can be made on solid evidence.
We translate intended product handling into study conditions that reflect realistic preparation and administration workflows rather than relying on generic hold-time models.
Each study uses methods chosen for the product risk profile, balancing assay, impurity, particulate, pH, and appearance testing to create a practical and technically credible dataset.
Comparative trending across diluents, temperatures, concentrations, and containers helps reveal the real drivers of in-use instability and informs risk reduction decisions.
We support challenging matrices such as suspensions, emulsions, high-concentration solutions, and reconstituted products where simple assay data alone is not enough to explain performance.
When project scope requires it, we align the study with relevant handling risks and incorporate supportive testing strategies such as microbial limit testing to strengthen the overall evaluation package.
Results are synthesized around development questions such as acceptable use windows, preferred diluents, handling limitations, and whether reformulation or packaging changes should be considered.
We design in-use studies for a wide range of drug products and development-stage presentations. Our work is especially valuable when product handling is complex, the formulation is sensitive, or the intended use pathway introduces meaningful stability or compatibility risk.
Share your dosage form, presentation, handling scenario, and key technical concern. Our scientists will translate them into a focused in-use study strategy with meaningful endpoints and decision-ready outputs.
We review dosage form, concentration range, packaging configuration, preparation steps, and intended handling conditions to define the study objective and identify the most relevant risk points.
Our team establishes conditions, timepoints, containers, diluents, and analytical endpoints, often leveraging knowledge from stability studies while keeping the design specific to active use scenarios.
Samples are prepared, stored, transferred, and monitored under defined conditions, with timepoint testing selected to capture both immediate incompatibility and gradual change during the intended in-use window.
We consolidate the full dataset into a clear technical report that explains observed trends, compares conditions, and outlines implications for handling recommendations, formulation optimization, or additional study needs.
Development teams often know their product will be opened, reconstituted, or diluted before administration, but lack robust data to define how long it remains suitable under practical use conditions. We address this by building targeted study models that capture the actual sequence of handling events and generate evidence that is more useful than generic bench-top observations.
Product behavior can shift quickly when concentration changes, surfaces increase, or contact materials vary. Our study designs compare likely use conditions side by side, helping teams identify compatibility-driven failures early and choose more robust preparation pathways.
For emulsions, suspensions, biologically derived products, and other sensitive systems, instability may first appear as subtle physical or interfacial change rather than immediate assay loss. We therefore combine orthogonal measurements and careful sample handling to reveal meaningful risk before it becomes a late-stage surprise.
Raw numbers alone rarely help a project team decide whether to reformulate, revise preparation instructions, or narrow a use window. BOC Sciences focuses on interpretation as well as execution, converting analytical outcomes into development guidance that is easier for CMC, formulation, and project stakeholders to use.
Partner with BOC Sciences to understand how your drug product behaves after opening, reconstitution, dilution, and transfer so your team can move forward with more confidence and fewer avoidable risks.
We model the way products are actually handled, helping teams generate data that reflects operational reality rather than idealized storage-only conditions.
Our scientists draw on analytical testing and release capabilities to build efficient, fit-for-purpose testing packages for each formulation and presentation.
Results are organized so formulation scientists, CMC leaders, project managers, and external partners can quickly understand what changed, why it changed, and what to do next.
Whether you are refining an early presentation concept or strengthening a more mature product package, we adapt the scope to match your technical question and development priorities.
Client Needs: A sponsor developing a lyophilized peptide injection needed to understand whether the reconstituted solution could tolerate the full preparation and administration workflow used by hospital staff.
Challenges: The product showed early signs of haze formation after reconstitution, but the mechanism was unclear and the client needed to know whether concentration, diluent selection, or short-term hold conditions were responsible.
Solution: BOC Sciences designed an in-use study covering multiple diluents, reconstitution techniques, storage conditions, and simulated administration intervals. We combined appearance checks, assay testing, impurity monitoring, pH trending, and particulate-focused observations to build a condition-by-condition performance map.
Outcome: The final data package identified the most robust reconstitution pathway, clarified the practical use window, and helped the client refine product handling recommendations before moving into broader development activities.
Client Needs: A pharmaceutical team needed to evaluate a concentrated injectable that would be diluted into IV bags before administration and wanted to compare performance across common preparation conditions.
Challenges: The product had a narrow tolerance for pH drift and a history of adsorption concerns, raising questions about contact with bags, tubing, and different dilution environments during use.
Solution: We executed a comparative in-use design across selected dilution media, concentration levels, bag materials, and simulated administration holds. The study incorporated orthogonal testing and structured data interpretation to distinguish true instability from handling-driven variation.
Outcome: The client received a clear ranking of preferred preparation conditions and a practical understanding of where compatibility risk emerged, making subsequent formulation and operational decisions much easier.
Client Needs: A biotech company developing a multi-dose presentation wanted to understand whether repeated entry and short-term in-use storage could affect appearance, concentration, and overall product robustness.
Challenges: Repeated puncture and withdrawal events created the possibility of concentration shifts, subtle physical change, and inconsistent sample behavior over time, especially as headspace and container dynamics evolved.
Solution: BOC Sciences built a repeated-access study model that simulated practical withdrawal patterns and monitored the product across predefined use intervals. The analytical package was structured to reveal trend direction, not just isolated timepoint results, improving the value of the final interpretation.
Outcome: The study gave the client a much stronger basis for assessing multi-dose feasibility, identifying the conditions that supported acceptable in-use performance and highlighting where further optimization would add value.
In-use studies help drug developers understand how a product behaves after opening, reconstitution, dilution, transfer, mixing, or contact with containers and administration-related materials. They evaluate whether handling steps may affect key product attributes, appearance, assay response, degradation profile, particle behavior, or material compatibility. This is especially valuable when the final use process includes multiple preparation steps or exposure to different surfaces. Industry discussions describe in-use studies as a way to simulate real handling conditions and assess stability and compatibility during the intended in-use period.
In-use studies are commonly considered when a drug product is not used immediately in its original closed container, or when preparation steps could influence product performance. Examples include reconstitution, dilution, transfer into syringes or bags, temporary holding, light or temperature exposure, and contact with tubing, filters, or other process-related materials. BOC Sciences can support clients by helping translate expected use scenarios into practical study designs that reflect formulation type, handling sequence, and development-stage questions without overcomplicating the study scope.
A strong in-use study usually tests representative product strengths, container types, diluents, hold conditions, contact materials, and handling steps that are most relevant to real product use. Because it is not practical to test every possible combination, study design often focuses on scientifically justified worst-case or representative scenarios. BOC Sciences’ stability and analytical service platforms can help clients select meaningful test points, define appropriate sample handling plans, and generate comparable analytical data across different in-use conditions.
In-use studies provide development teams with evidence on whether a formulation remains suitable during expected handling and temporary holding. The data can reveal sensitivity to dilution, agitation, container contact, pH shift, temperature exposure, or interaction with commonly used materials. These findings can guide formulation optimization, excipient selection, container strategy, and preparation instructions. BOC Sciences supports formulation and stability evaluation with analytical development, quality control, and stability testing capabilities for small molecules, biologics, and finished dosage forms.
Clients usually expect a clear study summary covering the tested preparation process, sample matrix, holding conditions, analytical methods, observations, comparative trends, and interpretation of whether product attributes remained consistent during the evaluated in-use period. Useful outputs may include assay-related results, degradation trends, appearance observations, particulate or droplet-size data when relevant, and compatibility conclusions for selected materials. BOC Sciences can help organize these results into development-focused reports that support internal decision-making and future product strategy.
BOC Sciences understood that we did not need generic stability data. We needed a study that mirrored how the product was actually prepared and handled. Their design was thoughtful and immediately useful.
— Senior Formulation Scientist, Injectable Programs
The team did more than generate results. They explained which trends mattered, which ones were condition-specific, and where we should focus our next round of development work.
— Dr. Lewis T., CMC Director
The report made it much easier for our formulation, analytical, and project teams to align on a realistic handling strategy. The study outputs were clear, focused, and commercially relevant.
— Head of Pharmaceutical Development, EU Biotech
Our formulation was sensitive and the in-use questions were not straightforward. BOC Sciences approached the problem methodically and helped us narrow the most credible path forward.
— Project Manager, Specialty Drug Product Team
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
